Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

c-myc oncoprotein levels in bladder cancer.

J R Masters1, S G Vesey, C F Munn

  • 1Institute of Urology, St. Paul's Hospital, London, United Kingdom.

Urological Research
|January 1, 1988
PubMed
Summary

High levels of the p62c-myc oncoprotein may predict better outcomes for bladder cancer patients. This finding suggests oncoprotein levels could be a significant prognostic marker for transitional cell carcinoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sall2 is required for proapoptotic Noxa expression and genotoxic stress-induced apoptosis by doxorubicin.

Cell death & disease·2015
Same author

Plexin-B1 signalling promotes androgen receptor translocation to the nucleus.

Oncogene·2015
Same author

The kinetics of ER fusion protein activation in vivo.

Oncogene·2014
Same author

Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death.

Cell death & disease·2013
Same author

Synthesis of peptides for use as immunogens.

Methods in molecular biology (Clifton, N.J.)·2012
Same author

Production and characterization of antibodies against synthetic peptides.

Methods in molecular biology (Clifton, N.J.)·2012

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The c-myc oncogene plays a crucial role in cell proliferation and differentiation.
  • Dysregulation of c-myc is implicated in various human cancers, including bladder cancer.
  • p62c-myc is a specific oncoprotein product of the c-myc oncogene.

Purpose of the Study:

  • To investigate the potential prognostic significance of p62c-myc oncoprotein levels in human bladder transitional cell carcinomas.
  • To correlate p62c-myc expression levels with disease recurrence and invasiveness.

Main Methods:

  • Monoclonal antibodies were used to measure p62c-myc protein levels.
  • Flow cytometry was employed for quantification of oncoprotein in cell nuclei.
  • Analysis was performed on paraffin-wax-embedded tissue sections from bladder cancer patients.

Related Experiment Videos

Main Results:

  • Significantly higher p62c-myc oncoprotein levels were observed in superficial bladder tumors (pTa and pT1) that did not recur within 5 years.
  • Lower oncoprotein levels were found in tumors that recurred or were muscle-invasive (pT2 or greater).
  • A statistically significant difference (P < 0.01) was noted between these groups.

Conclusions:

  • Preliminary findings suggest that p62c-myc oncoprotein levels may serve as a prognostic indicator for bladder cancer.
  • Elevated p62c-myc expression could be associated with a favorable prognosis in non-muscle-invasive disease.
  • Further research is warranted to validate these findings in larger cohorts.